Wanzhou Zhao

596 total citations
21 papers, 481 citations indexed

About

Wanzhou Zhao is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Wanzhou Zhao has authored 21 papers receiving a total of 481 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Wanzhou Zhao's work include Natural product bioactivities and synthesis (3 papers), Acute Myeloid Leukemia Research (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). Wanzhou Zhao is often cited by papers focused on Natural product bioactivities and synthesis (3 papers), Acute Myeloid Leukemia Research (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). Wanzhou Zhao collaborates with scholars based in China, Germany and United States. Wanzhou Zhao's co-authors include Rui Han, Kurt S. Zaenker, Frank Entschladen, Bernd Niggemann, Jian Ouyang, Haitao Li, Qicheng Fang, Hongyan Liu, Jinhua Wang and Yibing Zhao and has published in prestigious journals such as PLoS ONE, Annals of the New York Academy of Sciences and European Journal of Pharmacology.

In The Last Decade

Wanzhou Zhao

21 papers receiving 469 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wanzhou Zhao China 12 296 108 73 63 61 21 481
Roberta R. Ruela-de-Sousa Brazil 11 382 1.3× 85 0.8× 99 1.4× 47 0.7× 25 0.4× 12 556
Haiyan Sun China 8 242 0.8× 54 0.5× 42 0.6× 65 1.0× 45 0.7× 22 519
Weili Min China 17 299 1.0× 98 0.9× 132 1.8× 45 0.7× 37 0.6× 26 591
Qin Dong China 12 269 0.9× 59 0.5× 74 1.0× 43 0.7× 41 0.7× 35 499
Sang‐Mi Woo South Korea 10 208 0.7× 59 0.5× 81 1.1× 35 0.6× 38 0.6× 12 379
Xianjun Yu China 14 286 1.0× 63 0.6× 57 0.8× 50 0.8× 98 1.6× 20 454
Zhichao Xi China 15 320 1.1× 72 0.7× 123 1.7× 55 0.9× 31 0.5× 35 574
Myung-Soon Sung South Korea 7 212 0.7× 71 0.7× 56 0.8× 83 1.3× 29 0.5× 7 432

Countries citing papers authored by Wanzhou Zhao

Since Specialization
Citations

This map shows the geographic impact of Wanzhou Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wanzhou Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wanzhou Zhao more than expected).

Fields of papers citing papers by Wanzhou Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wanzhou Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wanzhou Zhao. The network helps show where Wanzhou Zhao may publish in the future.

Co-authorship network of co-authors of Wanzhou Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Wanzhou Zhao. A scholar is included among the top collaborators of Wanzhou Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wanzhou Zhao. Wanzhou Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Bo, Yu Zhang, Haidong Zhang, et al.. (2025). Luteolin inhibits diffuse large B-cell lymphoma cell growth through the JAK2/STAT3 signaling pathway. Frontiers in Pharmacology. 16. 1545779–1545779. 5 indexed citations
2.
3.
Zhao, Wanzhou, et al.. (2021). 7-Amino acid peptide (7P) decreased airway inflammation and hyperresponsiveness in a murine model of asthma. European Journal of Pharmacology. 912. 174576–174576. 3 indexed citations
4.
5.
Wang, Yingchun, Yinan Wu, Hui Yu, et al.. (2019). 3-acetyl-11-keto-beta-boswellic acid decreases the malignancy of taxol resistant human ovarian cancer by inhibiting multidrug resistance (MDR) proteins function. Biomedicine & Pharmacotherapy. 116. 108992–108992. 11 indexed citations
6.
Luo, Dongdong, Jiayu Yang, Shan Liu, et al.. (2019). Oridonin derivatives as potential anticancer drug candidates triggering apoptosis through mitochondrial pathway in the liver cancer cells. European Journal of Medicinal Chemistry. 178. 365–379. 37 indexed citations
7.
Zhao, Wanzhou, et al.. (2018). Breast Cancer Recurrence Risk Assessment: Is Non-Invasive Monitoring an Option?. PubMed. 3(3). 1–17. 10 indexed citations
8.
Luo, Dongdong, Jiayu Yang, Pawinee Piyachaturawat, et al.. (2018). Structural modification of oridonin via DAST induced rearrangement. RSC Advances. 8(52). 29548–29554. 10 indexed citations
9.
Jin, Lu, Suli Wang, Yingchun Wang, et al.. (2017). High WAVE3 expression correlates with proliferation, migration and invasion in human ovarian cancer. Oncotarget. 8(25). 41189–41201. 15 indexed citations
10.
Tong, Xiaoyong, Alok R. Khandelwal, Xiaojuan Wu, et al.. (2016). Pro-atherogenic role of smooth muscle Nox4-based NADPH oxidase. Journal of Molecular and Cellular Cardiology. 92. 30–40. 42 indexed citations
11.
Zhao, Wanzhou, et al.. (2014). NF-Kappa B Modulation Is Involved in Celastrol Induced Human Multiple Myeloma Cell Apoptosis. PLoS ONE. 9(4). e95846–e95846. 44 indexed citations
12.
Zhao, Wanzhou, et al.. (2013). Celastrol Inhibits Lipopolysaccharide-Induced Angiogenesis by Suppressing TLR4-Triggered Nuclear Factor-Kappa B Activation. Acta Haematologica. 131(2). 102–111. 38 indexed citations
13.
Wang, Ningning, Lijun Zhao, Mingfeng He, et al.. (2013). Mechanistic Analysis of Taxol-induced Multidrug Resistance in an Ovarian Cancer Cell Line. Asian Pacific Journal of Cancer Prevention. 14(9). 4983–4988. 35 indexed citations
14.
Zhao, Lijun, et al.. (2012). Modulation of Drug Resistance in Ovarian Cancer Cells by Inhibition of Protein Kinase C-alpha (PKC-α) with Small Interference RNA (siRNA) Agents. Asian Pacific Journal of Cancer Prevention. 13(8). 3631–3636. 23 indexed citations
15.
Zhao, Wanzhou, Lifeng Wang, Pingyan Chen, et al.. (2010). 7-aa Peptide Mimic from HVR1 of HCV Protects Hepatic Injury in Rats by Reduced Expression of Key Pro-Inflammatory Factors. Inflammation & Allergy - Drug Targets. 9(2). 135–145. 8 indexed citations
16.
Lu, Yin, Wanzhou Zhao, Zai Chang, Wenxin Chen, & Lin Li. (2004). Procyanidins from grape seeds protect against phorbol ester-induced oxidative cellular and genotoxic damage.. PubMed. 25(8). 1083–9. 24 indexed citations
17.
Campoli, Michael, et al.. (2004). Immunotherapy of Melanoma Targeting Human High Molecular Weight Melanoma‐Associated Antigen: Potential Role of Nonimmunological Mechanisms. Annals of the New York Academy of Sciences. 1028(1). 340–350. 30 indexed citations
18.
Wang, Fang, Yu Cao, Wanzhou Zhao, et al.. (2003). Taxol Inhibits Melanoma Metastases Through Apoptosis Induction, Angiogenesis Inhibition, and Restoration of E-Cadherin and nm23 Expression. Journal of Pharmacological Sciences. 93(2). 197–203. 15 indexed citations
19.
Zhao, Wanzhou, Frank Entschladen, Hongyan Liu, et al.. (2003). Boswellic acid acetate induces differentiation and apoptosis in highly metastatic melanoma and fibrosarcoma cells. Cancer Detection and Prevention. 27(1). 67–75. 98 indexed citations
20.
Zhao, Wanzhou, Hongyan Liu, Shaofeng Xu, et al.. (2001). Migration and metalloproteinases determine the invasive potential of mouse melanoma cells, but not melanin and telomerase. Cancer Letters. 162. S49–S55. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roberta R. Ruela-de-Sousa Breakdown of academic impact, for papers by Haiyan Sun Breakdown of academic impact, for papers by Weili Min Breakdown of academic impact, for papers by Qin Dong Breakdown of academic impact, for papers by Sang‐Mi Woo Breakdown of academic impact, for papers by Xianjun Yu Breakdown of academic impact, for papers by Zhichao Xi Breakdown of academic impact, for papers by Myung-Soon Sung
Rankless by CCL
2026